5/17/2013

Kevin Lobo, Stryker's president and CEO, told investors at a recent conference in Las Vegas that his company plans to pursue more buyouts after its recent purchases of Orthovita, Surpass and Trauson. Lobo also said that the biggest drivers for Stryker's growth are its medical-surgery and reconstructive-knee devices, which account for more than 65% of U.S. sales.

Related Summaries